Magnetic resonance angiography and computed tomography angiography for peripheral arterial disease

Imaging

Volumn 21, Issue 2, 2009, Pages 85-108

  Roditi, G ^a   Kusumawidjaja, D ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ABDOMINAL AORTA ANEURYSM; ARTERY DISEASE; ATHEROSCLEROTIC PLAQUE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL; REVIEW; THREE DIMENSIONAL IMAGING; TIBIAL ARTERY;

EID: 77956566506     PISSN: 09656812     EISSN: None     Source Type: Journal    
DOI: 10.1259/imaging/55671114     Document Type: Review

References (114)

1. Beard JD. ABC of arterial and venous disease: Chronic lower limb ischaemia. BMJ 2000;320:854-7.
2. Rutherford RB, Baker JD, Ernst C. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38. (Pubitemid 27408567)
3. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:1608-21.
4. Hiatt WR. Pharmacologic therapy for peripheral arterial disease and claudication. J Vasc Surg 2002;36:1283-91.
5. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 2002;347:1941-51.
6. Timaran CH, Prault TL, Stevens SL, Freeman MB, Goldman MH. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg 2003;38:272-8.
7. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67.
8. Pentecost MJ, Criqui MH, Dorros G, Goldstone J, Johnston KW, Martin EC, et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. [reprint in J Vasc Interv Radiol 2003;14:S495-515; PMID: 14514865]. Circulation 1994;89:511-31.
9. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
10. Hessel SJ, Adams DF, Abrams HL. Complications of angiography. Radiology 1981;138:273-81.
11. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84.
12. Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology. Br J Radiol 2008;81:362-78.
13. Thomsen HS, Morcos SK, Barrett BJ. Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 2008;49:646-57.
14. Morcos SK. Prevention of contrast media-induced nephrotoxicity after angiographic procedures. JVIR 2005;16:13-23. (Pubitemid 40096499)
15. Bosanac Z, Miller RJ, M. J. Rotational digital subtraction carotid angiography: technique and comparison with static digital subtraction angiography. Clin Radiol 1998;53:682-7.
16. Elgersma OE, Wust AF, Buijs PC, van Der Graaf Y, Eikelboom BC, et al. Multidirectional depiction of internal carotid arterial stenosis: three-dimensional time-of-flight MR angiography versus rotational and conventional digital subtraction angiography. Radiology 2000;216:511-16.
17. Ota H, Takase K, Rikimaru H, Tsuboi M, Yamada T, Sato A, et al. Quantitative vascular measurements in arterial occlusive disease. Radiographics 2005;25:1141-58. (Pubitemid 41695335)
18. AbuRahma AF, Robinson PA, Boland JP, Umstot RK, Clubb EA, Grandia RA, et al. Complications of arteriography in a recent series of 707 cases: factors affecting outcome. Ann Vasc Surg 1993;7:122-9.
19. Noorani A, Walsh SR, Cooper DG, Varty K. Entrapment syndromes. Eur J Vasc Endovasc Surg 2009;37:213-20.
20. Pillai J. A current interpretation of popliteal vascular entrapment. J Vasc Surg 2008;48(Suppl. 6):61S-5S; discussion 5S.
21. Napel S, Marks M, Rubin G, Dake M, McDonnell C, Song S, et al. CT angiography with spiral CT and maximum intensity projection. Radiology 1992;185:607-10.
22. Rubin GD, Shiau MC, Schmidt AJ, Fleischmann D, Logan L, Leung AN, et al. Computed tomographic angiography: historical perspective and new state-of-the-art using multi detector-row helical computed tomography. J Comp Ass Tomogr 1999;23.
23. Rubin GD, Schmidt AJ, Logan LJ, Sofilos MC. Multidetector row CT angiography of lower extremity arterial inflow and runoff: initial experience. Radiology 2001; 221:146-58.
24. Martin ML, Tay KH, Flak B, Fry PD, Doyle DL, Taylor DC, et al. Multidetector CT angiography of the aortoiliac system and lower extremities: a prospective comparison with digital subtraction angiography. AJR Am J Roentgenol 2003;180:1085-91. (Pubitemid 36363055)
25. Hallett RL, Fleischmann D. Tools of the trade for CTA: MDCT scanners and contrast medium injection protocols. Tech Vasc Interv Radiol 2006;9:134-42. (Pubitemid 47259424)
26. Fleischmann D, Rubin GD, Bankier AA, Hittmair K. Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography. Radiology 2000;214:363-71. (Pubitemid 30077690)
27. Cademartiri F, Mollet N, van der Lugt A, Nieman K, Pattynama PM, de Feyter PJ, et al. Non-invasive 16-row multislice CT coronary angiography: usefulness of saline chaser. Eur Radiol 2004;14:178-83. (Pubitemid 38181073)
28. Cademartiri F, Luccichenti G, Marano R, Runza G, Midiri M. Use of saline chaser in the intravenous administration of contrast material in non-invasive coronary angiography with 16-row multislice computed tomography. Radiol Med 2004;107:497-505. (Pubitemid 38937528)
29. Schindera ST, Nelson RC, Howle L, Nichols E, DeLong DM, Merkle EM. Effect of varying injection rates of a saline chaser on aortic enhancement in CT angiography: phantom study. Eur Radiol 2008;18:1683-9.
30. Fleischmann D, Hallett RL, Rubin GD. CT angiography of peripheral arterial disease. JVIR 2006;17:3-26.
31. Owen RS, Baum RA, Carpenter JP, Holland GA, Cope C. Symptomatic peripheral vascular disease: selection of imaging parameters and clinical evaluation with MR angiography. Radiology 1993;187:627-35. (Pubitemid 23155685)
32. Kaufman JA, McCarter D, Geller SC, Waltman AC. Two-dimensional time-of-flight MR angiography of the lower extremities: artifacts and pitfalls. AJR Am J Roentgenol 1998;171:129-35. (Pubitemid 28308662)
33. Steinberg FL, Yucel EK, Dumoulin CL, Souza SP. Peripheral vascular and abdominal applications of MR flow imaging techniques. Magn Reson Med 1990;14: 315-20.
34. Sivananthan UM, Ridgway JP, Bann K, Verma SP, Cullingworth J, Ward J, et al. Fast magnetic resonance angiography using turbo-FLASH sequences in advanced aortoiliac disease. Br J Radiol 1993;66:1103-10. (Pubitemid 23360041)
35. Prince MR, Yucel EK, Kaufman JA, Harrison DC, Geller SC. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Res Imaging 1993;3:877-81.
36. Prince MR, Narasimham DL, Stanley JC, Chenevert TL, Williams DM, Marx MV, et al. Breath-hold gadoliniumenhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-92.
37. Hany TF, McKinnon GC, Leung DA, Pfammatter T, Debatin JF. Optimization of contrast timing for breath-hold threedimensional MR angiography. J Magn Reson Imaging 1997;7:551-6. (Pubitemid 28360874)
38. Riederer SJ, Fain SB, Kruger DG, Busse RF. Real-time imaging and triggering of 3D contrast-enhanced MR angiograms using MR fluoroscopy. Magma 1999;8:196-206.
39. Willinek WA, Gieseke J, Conrad R, Strunk H, Hoogeveen R, von Falkenhausen M, et al. Randomly segmented central kspace ordering in high-spatial-resolution contrast-enhanced MR angiography of the supraaortic arteries: initial experience. Radiology 2002;225:583-8.
40. Meaney JF, Ridgway JP, Chakraverty S, Robertson I, Kessel D, Radjenovic A, et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 1999;211:59-67. (Pubitemid 29161734)
41. Leiner T, Nijenhuis RJ, Maki JH, Lemaire E, Hoogeveen R, van Engelshoven JM. Use of a three-station phased array coil to improve peripheral contrast-enhanced magnetic resonance angiography. J Magn Res Imaging 2004; 20:417-25. (Pubitemid 39121940)
42. Bezooijen R, van den Bosch HC, Tielbeek AV, Thelissen GR, Visser K, Hunink MG, et al. Peripheral arterial disease: sensitivity-encoded multiposition MR angiography compared with intraarterial angiography and conventional multiposition MR angiography. Radiology 2004;231:263-71. (Pubitemid 38375437)
43. Korosec FR, Frayne R, Grist TM, Mistretta CA. Timeresolved contrast-enhanced 3D MR angiography. Magn Res Med 1996;36:345-51.
44. Swan JS, Carroll TJ, Kennell TW, Heisey DM, Korosec FR, Frayne R, et al. Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vessels. Radiology 2002;225:43-52.
45. Mell M, Tefera G, Thornton F, Siepman D, Turnipseed W. Clinical utility of time-resolved imaging of contrast kinetics (TRICKS) magnetic resonance angiography for infrageniculate arterial occlusive disease. J Vasc Surg 2007;45:543-8; discussion 8.
46. Andreisek G, Pfammatter T, Goepfert K, Nanz D, Hervo P, Koppensteiner R, et al. Peripheral arteries in diabetic patients: standard bolus-chase and time-resolved MR angiography. Radiology 2007;242:610-20.
47. Hahn WY, Hecht EM, Friedman B, Babb JS, Jacobowitz GR, Lee VS. Distal lower extremity imaging: prospective comparison of 2-dimensional time of flight, 3-dimensional time-resolved contrast-enhanced magnetic resonance angiography, and 3-dimensional bolus chase contrastenhanced magnetic resonance angiography. J Comp Ass Tomogr 2007;31:29-36.
48. Kreitner K-F, Kunz RP, Herber S, Martenstein S, Dorweiler B, Dueber C. MR angiography of the pedal arteries with gadobenate dimeglumine, a contrast agent with increased relaxivity, and comparison with selective intraarterial DSA. J Magn Res Imaging 2008;27:78-85.
49. Willinek WA, Hadizadeh DR, von Falkenhausen M, Urbach H, Hoogeveen R, Schild HH, et al. 4D time-resolved MR angiography with keyhole (4D-TRAK): more than 60 times accelerated MRA using a combination of CENTRA, keyhole, and SENSE at 3.0T. J Magn Res Imaging 2008; 27:1455-60.
50. Ruhl KM, Katoh M, Langer S, Mommertz G, Guenther RW, Niendorf T, et al. Time-resolved 3D MR angiography of the foot at 3 T in patients with peripheral arterial disease. AJR Am J Roentgenol 2008;190:W360-4.
51. Lohan DG, Tomasian A, Saleh RS, Singhal A, Krishnam MS, Finn JP. Ultra-low-dose, time-resolved contrast-enhanced magnetic resonance angiography of the carotid arteries at 3.0 tesla. Invest Radiol 2009;44:207-17.
52. Hadizadeh DR, Gieseke J, Lohmaier SH, Wilhelm K, Boschewitz J, Verrel F, et al. Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA. Radiology 2008;249:701-11.
53. Meaney JFM, Goyen M. Recent advances in contrast-enhanced magnetic resonance angiography. Eur Radiol 2007;17 (Suppl. 2):B2-6.
54. Michaely HJ, Attenberger UI, Dietrich O, Schmitt P, Nael K, Kramer H, et al. Feasibility of gadofosveset-enhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation. Invest Radiol 2008;43:635-41.
55. Hiraishi K, Narabayashi I, Fujita O, Yamamoto K, Sagami A, Hisada Y, et al. Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging. Radiology 1995;194:119-23.
56. Ruehm SG, Nanz D, Baumann A, Schmid M, Debatin JF. 3D contrast-enhanced MR angiography of the run-off vessels: value of image subtraction. J Magn Res Imaging 2001;13:402-11.
57. Herborn CU, Vogt FM, Waltering KU, Reiter KB, Kniemeyer HW, Barkhausen J. Optimization of contrast-enhanced peripheral MR angiography with mid-femoral venous compression (VENCO). Rofo 2004;176:157-62.
58. Zhang HL, Ho BY, Chao M, Kent KC, Bush HL, Faries PL, et al. Decreased venous contamination on 3D gadoliniumenhanced bolus chase peripheral mr angiography using thigh compression. AJR Am J Roentgenol 2004;183:1041-7.
59. Bilecen D, Aschwanden M, Heidecker HG, Bongartz G. Optimized assessment of hand vascularization on contrastenhanced MR angiography with a subsystolic continuous compression technique. AJR Am J Roentgenol 2004; 182:180-2.
60. Morasch MD, Collins J, Pereles FS, Carr JC, Eskandari MK, Pearce WH, et al. Lower extremity stepping-table magnetic resonance angiography with multilevel contrast timing and segmented contrast infusion. J Vasc Surg 2003;37: 62-71.
61. Owen AR, Robertson IR, Annamalai G, Roditi GH, Edwards RD, Murray LS, et al. Critical lower-limb ischemia: the diagnostic performance of dual-phase injection MR angiography (including high-resolution distal imaging) compared with digital subtraction angiography. JVIR 2009;20:165-72.
62. Ota H, Takase K, Igarashi K, Chiba Y, Haga K, Saito H, et al. MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: importance of reviewing cross-sectional images. AJR Am J Roentgenol 2004;182:201-9.
63. Edwards AJ, Wells IP, Roobottom CA. Multidetector row CT angiography of the lower limb arteries: a prospective comparison of volume-rendered techniques and intraarterial digital subtraction angiography. Clin Radiol 2005;60:85-95.
64. Roos JE, Fleischmann D, Koechl A, Rakshe T, Straka M, Napoli A. Multipath curved planar reformation of the peripheral arterial tree in CT angiography. Radiology 2007;244:281-90.
65. Ouwendijk R, Kock MCJM, Visser K, Pattynama PMT, de Haan MW, Hunink MGM. Interobserver agreement for the interpretation of contrast-enhanced 3D MR angiography and MDCT angiography in peripheral arterial disease. AJR. Am J Roentgenol 2005;185:1261-7.
66. Ouwendijk R, Kock MCJM, van Dijk LC, van Sambeek MRHM, Stijnen T, Hunink MGM. Vessel wall calcifications at multi-detector row CT angiography in patients with peripheral arterial disease: effect on clinical utility and clinical predictors. Radiology 2006;241:603-8.
67. Kock MC, Dijkshoorn ML, Pattynama PM, Myriam Hunink MG. Multi-detector row computed tomography angiography of peripheral arterial disease. Eur Radiol 2007; 17:3208-22.
68. Harris PL, Buth J. An update on the important findings from the EUROSTAR EVAR registry. Vascular 2004;12:33-8.
69. Armerding MD, Rubin GD, Beaulieu CF, Slonim SM, Olcott EW, Samuels SL, et al. Aortic aneurysmal disease: assessment of stent-graft treatment - CT versus conventional angiography. Radiology 2000;215:138-46.
70. Hagan PG, Nienaber CA, Isselbacher EM. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000;283:897-903.
71. 1-weighted imaging. Clin Radiol 2000;55:136-9.
72. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of highdose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1996;6:162-6.
73. Zhang H, Prince MR, editors. Safety of gadolinium contrast for high-dose MRA. London, Ontario: MRA Club, 2004.
74. Atilla S, Akpek ET, Yucel C, Tali ET, Isik S. MR imaging and MR angiography in popliteal artery entrapment syndrome. Eur Radiol 1998;8:1025-9.
75. Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA 2001;285:1338-45.
76. Visser K, Hunink MG. Peripheral arterial disease: gadolinium- enhanced MR angiography versus color-guided duplex US - a meta-analysis. Radiology 2000;216:67-77.
77. Leiner T, Kessels AG, Schurink GW, Kitslaar PJ, de Haan MW, Tordoir JH, et al. Comparison of contrast-enhanced magnetic resonance angiography and digital subtraction angiography in patients with chronic critical ischemia and tissue loss. Invest Radiol 2004;39:435-44.
78. Li GC, Deng G, Qin YL. The comparative study of 64-slices spiral CT angiography with DSA in lower extremity arterial occlusive diseases. J Interv Radiol 2008;17:336-9.
79. Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 2009;301:415-24.
80. Langer S, Kramer N, Mommertz G, Koeppel TA, Jacobs MJ, Wazirie NA, et al. Unmasking pedal arteries in patients with critical ischemia using time-resolved contrast-enhanced 3D MRA. J Vasc Surg 2009;49:1196-202.
81. Leiner T, Kessels AGH, Schurink GW, Kitslaar PJEHM, de Haan MW, Tordoir JHM, et al. Comparison of contrastenhanced magnetic resonance angiography and digital subtraction angiography in patients with chronic critical ischemia and tissue loss. Invest Radiol 2004;39:435-44.
82. Greenhalgh RM, Belch JJF, Brown LC, Gaines PA, Gao L, Reise JA, et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg 2008; 36:680-8.
83. Dorenbeck U, Seitz J, Volk M, Strotzer M, Lenhart M, Feuerbach S, et al. Evaluation of arterial bypass grafts of the pelvic and lower extremities with gadolinium-enhanced magnetic resonance angiography: comparison with digital subtraction angiography. Invest Radiol 2002;37:60-4.
84. Loewe C, Cejna M, Schoder M, Loewe-Grgurin M, Wolf F, Lammer J, et al. Contrast material-enhanced, moving-table MR angiography versus digital subtraction angiography for surveillance of peripheral arterial bypass grafts. JVIR 2003;14:1129-37.
85. Moody P, Gould DA, Harris PL. Vein graft surveillance improves patency in femoro-popliteal bypass. Eur J Vasc Surg 1990;4:117-21.
86. Costantini V, Lenti M. Treatment of acute occlusion of peripheral arteries. Thromb Res 2002;106:V285-V94.
87. Soto JA, Munera F, Morales C, Lopera JE, Holguin D, Guarin O, et al. Focal arterial injuries of the proximal extremities: helical CT arteriography as the initial method of diagnosis. Radiology 2001;218:188-94.
88. Klein WM, Schlejen PM, Eikelboom BC, van der Graaf Y, Mali WP. MR angiography of the lower extremities with a moving-bed infusion-tracking technique. CIR 2003;26:1-8.
89. Roditi GH, Fink C. Venous MR imaging with Blood Pool Agents. Eur Radiol Suppl 2009;18:E3-E12.
90. Fraioli F, Catalano C, Bertoletti L, Danti M, Fanelli F, Napoli A, et al. Multidetector-row CT angiography of renal artery stenosis in 50 consecutive patients: prospective interobserver comparison with DSA. Radiol Med 2006;111:459-68.
91. Willmann JK, Baumert B, Schertler T, Wildermuth S, Pfammatter T, Verdun FR, et al. Aortoiliac and lower extremity arteries assessed with 16-detector row CT angiography: prospective comparison with digital subtraction angiography. Radiology 2005;236:1083-93.
92. Wintersperger B, Jakobs T, Herzog P, Schaller S, Nikolaou K, Suess C, et al. Aorto-iliac multidetector-row CT angiography with low kV settings: improved vessel enhancement and simultaneous reduction of radiation dose. Eur Radiol 2005;15:334-41.
93. From AM, Bartholmai BJ, Williams AW, Cha SS, McDonald FS. Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clinic Proc 2008;83: 1095-100.
94. Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol 2009;4:1162-9.
95. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001;23:383-93.
96. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? [erratum appears in Nephrol Dial Transplant. 2006;21:1745]. Nephrol Dialysis Transplant 2006;21:1104-8.
97. Cowper SE. Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium. Adv Dermatol 2007;23:131-54.
98. Cowper SE. Nephrogenic systemic fibrosis: an overview. J Am Coll Radiol 2008;5:23-8.
99. Collidge TA, Thomson PC, Mark PB, Traynor JP, Jardine AG, Morris STW, et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 2007;245:168-75.
100. Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garrett RW, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148-57.
101. Roditi G. MRI contrast agent safety in renal impairment. Clin Risk 2009;15:47-53.
102. Leiner T, Gerretsen S, le Maire T, Miller S, Thurnher S, Herborn CU, et al., editors. Multicenter, Intraindividual Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine for MRA of the Peripheral Arteries. ISMRM 17th Scientific Meeting & Exhibition; 18-24 April 2009, Hawaii.
103. Kramer H, Zenge M, Schmitt P, Glaser C, Reiser MF, Herrmann KA. Peripheral magnetic resonance angiography (MRA) with continuous table movement at 3.0 T: initial experience compared with step-by-step MRA. Invest Radiol 2008;43:627-34.
104. Westenberg JJ, van der Geest RJ, Wasser MN, van der Linden EL, van Walsum T, van Assen HC, et al. Vessel diameter measurements in gadolinium contrast-enhanced three-dimensional MRA of peripheral arteries. Magn Reson Imaging 2000;18:13-22.
105. McCarty M, Gedroyc WM. Surgical clip artefact mimicking arterial stenosis: a problem with magnetic resonance angiography. Clin Radiol 1993;48:232-5.
106. Trost DW, Zhang HL, Prince MR, Winchester PA, Wang Y, Watts R, et al. Three-dimensional MR angiography in imaging platinum alloy stents. J Magn Reson Imaging 2004;20:975-80.
107. Rubin GD. Data explosion: the challenge of multidetector-row CT. Eur J Radiol 2000;36:74-80.
108. Johnson TR, Krauss B, Sedlmair M. Material differentiation by dual energy CT: initial experience. Eur Radiol 2007;17:1510-17.
109. Brockmann C, Jochum S, Sadick M, Huck K, Ziegler P, Fink C, et al. Dual-energy CT angiography in peripheral arterial occlusive disease. Cardiovasc Intervent Radiol 2009; Published Online January 2009.
110. Sommer WH, Nikolaou K. Case 4: Identification of vessel stenosis of the lower leg by dynamic CT-angiography using the SOMATOM definition AS+. SOMATOM Sessions 2008;23:32-3.
111. Potthast S, Wilson GJ, Wang MS, Maki JH. Peripheral moving-table contrast-enhanced magnetic resonance angiography (CE-MRA) using a prototype 18-channel peripheral vascular coil and scanning parameters optimized to the patient's individual hemodynamics. J Magn Reson Imaging 2009;29:1106-15.
112. Lim RP, Hecht EM, Xu J, Babb JS, Oesingmann N, Wong S, et al. 3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging 2008;28:181-9.
113. Ouwendijk R, de Vries M, Pattynama PMT, van Sambeek MRHM, de Haan MW, Stijnen T, et al. Imaging peripheral arterial disease: a randomized controlled trial comparing contrast-enhanced MR angiography and multi-detector row CT angiography. Radiology 2005;236:1094-103.
114. Collins R, Burch J, Cranny G, Aguiar-Ibanez R, Craig D, Wright K, et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ 2007;334:1257.